Bio-Techne Corporation (TECH) — closed signal from October 21, 2025
Partial Published before the outcome was known, scored automatically when the window closed on January 19, 2026.
Predicted vs. what happened
What happened
Reached 64% of the predicted growth at its peak, without hitting the target.
The thesis — published October 21, 2025
Bio-Techne shows a strengthening trend: lots more people are buying than usual, and the price is above its recent average. A new global distribution deal with Saguaro could widen reach, and shares rose about 20% last month. Risks remain because core sales growth looks muted. This is a short-term idea: consider buying small dips only if trading volume stays strong, aiming for a 0-3 month drift higher.
Primary drivers
- New global distribution deal with Saguaro may meaningfully expand reach
- Buying interest is rising and price is above its recent average
- Stock jumped 20% last month, showing strong demand from investors
- Core sales growth appears soft, so near-term results may be uneven
How it played out
TECH: thesis partly played out, target missed
Lyra published TECH on 2025-10-21 at $63.37 with an 18% expected gain and a $74.68 target. The thesis pointed to rising buying interest, a price above its recent average, a new global distribution deal with Saguaro, and a 20% jump last month. It also flagged soft core sales growth as a risk.
Inside the window, TECH rose but did not reach $74.68. The stock peaked at $70.66 on 2026-01-15, with an 11.5% gain, then ended at $68.67. The direction was right, but the target was missed. The thesis partly played out.
What happened during the window
On December 9, 2025, Bio-Techne announced the expanded launch and first shipment of its enhanced Leo System, saying it enabled up to 24 targets per sample. On December 11, 2025, Bio-Techne announced a collaboration with the Wyss Center Geneva to develop an automated workflow for RNA and protein detection in 3D specimens.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.